Author

Lokesh Kumar

Translational Health Science and Technology InstituteORCID 0000-0001-7073-9618Unclaimed ORCID profile · follow to get notified of new preprints

Additional preprints under this name without ORCID

Lokesh Kumar1 paper · Translational Health Science and Technology Institute

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell-cell communication· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

Banwari Lal· 1 shared Deepak Kumar RathoreiD· 1 shared Gagandeep SinghiD· 1 shared Garima Joshi· 1 shared Jaskaran KauriD· 1 shared Kamini JakhariD· 1 shared Mahima TiwariiD· 1 shared Mudita GosainiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Banwari Lal

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

ImmunologyFrontiers in ImmunologyPeer-reviewedJan 15, 2026

SARS-CoV-2 spike antibodies cross-react with dengue virus and enhance infection in vitro and in vivo

Kamini Jakhar, Sudipta Sonar, Gagandeep Singh…·Shailendra Mani

The paper shows that SARS-CoV-2 spike antibodies can enhance DENV2 infection in vitro and in vivo, suggesting potential for increased dengue severity in COVID-19 survivors.

12 citationstop 1%

mouseproteomics

𝕏 PostBluesky